All Clinical Trials

A listing of 23130 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Trials

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Studying an Investigational Virus Vaccine

Recruiting

The main objectives of this study are to assess the safety and effectiveness of an investigational vaccine aimed at preventing norovirus, commonly known as the stomach flu. Participants will be randomly assigned to receive either the investigational vaccine or a placebo. Should you express interest, you will be contacted directly by the research site, which will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.

Conditions:

Healthy

Interested in vaccine studies

All Conditions

Preventative Trials

Learn More

Featured Trial

Type 2 Diabetes Clinical Trial

Recruiting

Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.

Conditions:

Type 2 Diabetes

Diabetes Mellitus Type 2 in Obese

Diabetes Type Two

Type 2 Diabetes Mellitus

Diabete Type 2

Learn More

Featured Trial

Evaluating an Investigational Treatment for Hidradenitis Suppurativa

Recruiting

The main objectives of this Phase 2 study are to evaluate the safety and effectiveness of an investigational medication in adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition. Participants will be randomly assigned to receive the investigational treatment or a placebo. Should you express interest, the research site will contact you directly to provide further details and address any questions you may have about study requirements, risks/benefits, and compensation.

Conditions:

All Conditions

Hidradenitis suppurativa (Skin disorder)

Dermatology

Learn More

Featured Trial

Crohn's Disease Clinical Study

Recruiting

Help us study a potential new way to treat Crohn's disease. We are seeking adults living with Crohn's disease to join our latest clinical trial to help us learn more. Eligible participants will receive study-related treatment, assessments, and care at no cost. You will also receive reimbursement for travel while participating. Health insurance is not required to take part.

Conditions:

Crohn's Disease

Crohn Disease

Crohns Disease

Crohn's Disease (CD)

Crohn Colitis

Learn More

Featured Trial

Studying an Investigational Medication's Impact on Cardiovascular Events

Recruiting

The main objectives of this Phase 3 study are to evaluate the safety and effectiveness of an investigational medication's ability to reduce major adverse cardiovascular events (such as heart attacks and strokes) in adults at risk. Participants will be randomly assigned to receive either the investigational medication or a placebo. Should you express interest, you will be contacted directly by the research site, which will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.

Conditions:

All Conditions

Hyperlipidemia

Cardiovascular Disease

Ischemic heart disease (IHD)

Stroke

Learn More

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

NCT03435796

Recruiting

This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one infusion of GM T cells will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.

Gender:

ALL

Ages:

All

Trial Updated:

04/11/2025

Locations: University of Alabama Birmingham, Birmingham, Alabama +177 locations

University of Alabama Birmingham, Birmingham, Alabama

Banner MD Anderson Cancer Center, Gilbert, Arizona

Mayo Clinic Phoenix, Phoenix, Arizona

Arizona Cancer Center, Scottsdale, Arizona

Local Institution - 01021, Tucson, Arizona

City Of Hope, Duarte, California

University Of California San Diego Moores Cancer Center, La Jolla, California

Local Institution - 01206, Los Angeles, California

Local Institution - 01043, Sacramento, California

University of California, San Francisco- California, San Francisco, California

UCLA Medical Centre-Santa Monica, Santa Monica, California

Local Institution - 01119, Stanford, California

University Of Colorado Cancer Center, Aurora, Colorado

Colorado Blood Cancer Institute, Denver, Colorado

Yale Cancer Center, New Haven, Connecticut

Local Institution - 01050, Washington, District of Columbia

The Mayo Clinic - Jacksonville, Davis-E, Jacksonville, Florida

Baptist Cancer Center, Miami, Florida

Local Institution - 01035, Orlando, Florida

H. Lee Moffitt Cancer Center and Research Institute University of South Florida, Tampa, Florida

Winship Cancer Institute of Emory University, Atlanta, Georgia

Northside Hospital, Inc, Atlanta, Georgia

Northwestern Memorial Hospital, Chicago, Illinois

University Of Chicago Medical Center, Chicago, Illinois

Local Institution - 01040, Maywood, Illinois

Local Institution - 01063, Niles, Illinois

IN Univ Simon Cancer Center, Indianapolis, Indiana

Local Institution - 01020, Indianapolis, Indiana

Kansas University Medical Center, Westwood, Kansas

Cancer Center of Kansas, Wichita, Kansas

University Of Kentucky, Lexington, Kentucky

Norton Cancer Institute Louisville Oncology, Louisville, Kentucky

Local Institution - 01026, New Orleans, Louisiana

University of Maryland - Greenebaum Comprehensive Cancer Center, Baltimore, Maryland

Sidney Kimmel Comp Cancer Center at Johns Hopkins, Baltimore, Maryland

National Cancer Institute, Bethesda, Maryland

Local Institution - 01107, Boston, Massachusetts

Massachusetts General Hospital / Dana-Farber Cancer Institute, Boston, Massachusetts

Local Institution - 01106, Boston, Massachusetts

University Of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Karmanos Cancer Center Wayne State University, Detroit, Michigan

Providence Cancer Institute, Southfield, Michigan

M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis, Minnesota

Mayo Clinic, Rochester, Minnesota

Siteman Cancer Center, Saint Louis, Missouri

University Of Nebraska Medical Center, Omaha, Nebraska

Local Institution - 01030, East Brunswick, New Jersey

Hackensack University Medical Center, Hackensack, New Jersey

Morristown Memorial Hosp, Morristown, New Jersey

Local Institution - 01053, New Brunswick, New Jersey

New York Oncology Hematology P.C., Albany, New York

Roswell Park Cancer Institute, Buffalo, New York

Local Institution - 01066, New York, New York

Weill Cornell Medicine / New York Presbyterian Hospital, New York, New York

Icahn School Of Medicine At Mount Sinai, New York, New York

Columbia University Medical Center/New York-Presbyterian Hospital, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Local Institution - 01051, Rochester, New York

Levine Cancer Institute, Charlotte, North Carolina

Duke University Medical Center, Durham, North Carolina

Local Institution - 01058, Salisbury, North Carolina

Oncology Hematology Care, Inc., Cincinnati, Ohio

Local Institution - 01042, Cleveland, Ohio

Cleveland Clinic Foundation, Cleveland, Ohio

Local Institution - 01074, Columbus, Ohio

University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City, Oklahoma

Willamette Valley Cancer Institute, Eugene, Oregon

Providence Portland Medical Center, Portland, Oregon

Oregon Health and Science University OHSU, Portland, Oregon

Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia, Pennsylvania

University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania

Thomas Jefferson University - Clinical Research Institute, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

UPMC Cancer Pavillion, Pittsburgh, Pennsylvania

Hematology and Oncology Associates of SC, LLC, Greenville, South Carolina

Local Institution - 01064, Sioux Falls, South Dakota

Sarah Cannon Research Inst, Nashville, Tennessee

Texas Oncology, Dallas, Texas

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas

UT Southwestern Medical Center, Dallas, Texas

University of Texas- MD Anderson, Houston, Texas

Sam Clinical Research Center, San Antonio, Texas

Local Institution - 01033, Temple, Texas

Texas Oncology, P.A. - Tyler, Tyler, Texas

University of Utah - Huntsman Cancer Institute, Salt Lake City, Utah

Intermountain Healthcare - LDS Hospital, Salt Lake City, Utah

University Of Virginia Health System, Charlottesville, Virginia

Local Institution - 01045, Norfolk, Virginia

Local Institution - 01023, Richmond, Virginia

Swedish Cancer Institute, Seattle, Washington

Local Institution - 01060, Seattle, Washington

Fred Hutchinson Cancer Center, Seattle, Washington

Local Institution - 01055, Tacoma, Washington

University Of Wisconsin, Madison, Wisconsin

Froedtert Hospital BMT Medical College of Wisconsin, Milwaukee, Wisconsin

Local Institution - 01069, Wauwatosa, Wisconsin

Allgemeinen Krankenhaus (AKH) Wien - Medizinische Universitaet Wien, Wien, Not set

Local Institution - 05202, Anderlecht, Not set

Universitair Ziekenhuis Brussel, Brussel, Not set

Local Institution - 05200, Gent, Not set

Uz Gent, Gent, Not set

University Hospital Leuven, Leuven, Not set

Local Institution - UNK 2, Leuven, Not set

University Of Calgary, Calgary, Alberta

Local Institution - 02802, Vancouver, British Columbia

Local Institution - 02801, Hamilton, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

CIUSSS de l'Est-de-l'Ile-de-Montreal, Montreal, Quebec

Helsinki University Central Hospital (HUCH), Helsinki, Not set

Hopital Henri Mondor, Creteil-Paris, Not set

CHRU de Lille France, Lille Cedex, Not set

Local Institution - 09601, Lyon, Not set

Local Institution - 09400, Marseille Cedex 9, Not set

Local Institution - 09602, Marseille Cedex 9, Not set

CHU Montpellier - Hôpital Saint Eloi, Montpellier CEDEX 5, Not set

Chu Hotel Dieu, Nantes Cedex 01, Not set

Hopital Saint Louis, Paris, Not set

Hospital Saint Louis, Paris, Not set

Local Institution - 09600, Paris, Not set

Local Institution - 09210, Pessac, Not set

Centre Hospitalier Lyon-Sud, Pierre-Benite CEDEX, Not set

CHU La Miletrie, Poitiers Cedex, Not set

Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse CEDEX 9, Not set

Gustave Roussy, Villejuif, Not set

Robert-Rossle-Klinik im HELIOS Klinikum Berlin-Buch Klinik fur Hamatologie, Onkologie u. Tumorimmuno, Berlin, Not set

Local Institution - 03155, Berlin, Not set

Universitatsklinikum Carl Gustav Carus an der TU Dresden, Dresden, Not set

Local Institution - 03513, Dusseldorf, Not set

Local Institution - 03500, Frankfurt, Not set

Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Not set

Universitatsklinikum Heidelberg, Heidelberg, Not set

Kinikum der Universitaeat zu Koeln, Koeln, Not set

Local Institution - 03454, Muenster, Not set

LMU Klinikum der Universität, München, Not set

Local Institution - 03503, Tuebingen, Not set

University Hospital of Ulm, Ulm, Not set

Universitatsklinikum Wurzburg Medizinische Klinik und Poliklinik II, Würzburg, Not set

Ospedali Riuniti di Ancona, Ancona, Not set

Azienda Ospedaliero Universitaria Di Bologna Policlinico Sorsola Malpighi, Bologna, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Not set

Fondazione Monza e Brianza per il Bambino e la sua Mamma (MBBM), Monza, Not set

Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale, Naples, Not set

Local Institution - 07500, Roma, Not set

Ospedale Pediatrico Bambino Gesu, Rome, Not set

Istituto Clinico Humanitas, Rozzano (MI), Not set

Local Institution - 07610, Torino, Not set

Azienda Sanitaria Ospedaliera San Giovanni Battista Molinette, Turin, Not set

Hokkaido University Hospital, Sapporo-shi, Hokkaido

National Cancer Center Hospital, Chuo-ku, Tokyo

Toranomon Hospital, Minato-ku, Tokyo

Local Institution - 13202, Bunkyo-ku, Not set

Kyushu University Hospital, Fukuoka, Not set

Tokai University Hospital, Isehara City, Kanagawa, Not set

Nagoya City University Hospital, Nagoya, Not set

Osaka Metropolitan university Hospital, Osaka, Not set

Japan Red Cross Medical Center, Shibuya-ku, Not set

Jichi Medical University Hospital, Shimotsuke, Not set

Local Institution - 13804, Shinjuku City, Not set

Local Institution - 04650, Amsterdam, Not set

Erasmus Medical Center - Daniel den Hoed, Rotterdam, Not set

Local Institution - 04400, Utrecht, Not set

Oslo Universitetssykehus, Oslo, Not set

Hospital Universitario Vall D hebron, Barcelona, Not set

Hospital Universitari Germans Trias i Pujol ICO Badalona, Barcelona, Not set

Institut Clinic de Nefrologia i Urologia - Hospital Clinic i Provincial de Barcelona, Barcelona, Not set

Hospital San Joan de Deu Barcelona, Esplugues de Llobregat, Not set

Hospital Infantil Universitario Nino Jesus, Madrid, Not set

Hospital 12 De Octubre, Madrid, Not set

Clinica Universidad de Navarra, Pamplona, Not set

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca, Not set

Hospital Virgen Del Rocio, Sevilla, Not set

Karolinska University Hospital Huddinge, Stockholm, Not set

Inselspital Bern, Bern, Not set

Local Institution - 10850, Leeds, Not set

Kings College Hospital, London, Not set

UCL Cancer Institute, London, Not set

Christie Hospital Nhs Trust, Manchester Withington, Not set

Somers Cancer Research Building, Shirley Southampton, Not set

Conditions: Neoplasms

Learn More ›

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

NCT03686124

Recruiting

The study purpose is to establish the safety and tolerability of IMA203/IMA203CD8 products with or without combination with nivolumab in patients with solid tumors that express preferentially expressed antigen in melanoma (PRAME).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: University of Miami Hospital and Clinics, Miami, Florida +12 locations

Conditions: Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer

Learn More ›

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

NCT04449874

Recruiting

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: City of Hope Comprehensive Cancer Center, Duarte, California +73 locations

City of Hope Comprehensive Cancer Center, Duarte, California

UCSD Moores Cancer Center, La Jolla, California

Chao Family Comprehensive Cancer Center UCI, Orange, California

Univ of Calif, San Francisco, San Francisco, California

Yale Cancer Center, New Haven, Connecticut

Florida Cancer Specialists - Sarasota, Sarasota, Florida

Dana Farber Cancer Institute, Boston, Massachusetts

Memorial Sloan Kettering Cancer Center, New York, New York

University of Oklahoma, Oklahoma City, Oklahoma

Abramson Cancer Center, Philadelphia, Pennsylvania

UPMC - Hillman Cancer Center, Pittsburgh, Pennsylvania

St Vincent's Hospital Sydney, Darlinghurst, New South Wales

Slade Health Inward goods, Mount Kuring-gai, New South Wales

Peter MacCallum Cancer Center, Melbourne, Victoria

Alfred Health, Melbourne, Victoria

Linear Clinical Research Limited, Nedlands, Western Australia

UZ Antwerpen, Edegem, Not set

CHU de Liège, Liège, Not set

AZ St Maarten Campus Leopoldstr, Mechelen, Not set

Santa Casa de Misericordia de Belo Horizonte - PPDS, Belo Horizonte, Minas Gerais

Hospital Erasto Gaertner, Curitiba, Paraná

Hospital de Clinicas de Porto Alegre HCPA PPDS, Porto Alegre, Pará

Universidade de Caxias do Sul, Caxias Do Sul, Rio Grande Do Sul

Hospital Sao Lucas Da Pontificia Universidade Catolica Do Rio Grande Do Sul (PUCRS), Porto Alegre, Rio Grande Do Sul

Hospital de Cancer de Barretos, Barretos, São Paulo

Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS, Sao Jose Do Rio Preto, São Paulo

Instituto do Cancer do Estado de Sao Paulo - ICESP, Sao Paulo, São Paulo

Instituto Nacional de Câncer, Rio de Janeiro, Not set

Ottawa Hospital, Ottawa, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

Jewish General Hospital, Montreal, Quebec

Semmelweis Egyetem, Budapest, Not set

Clinexpert Gyongyos Kft, Gyöngyös, Not set

Rambam Medical Center, Haifa, Not set

Sheba Medical Center - PPDS, Ramat Gan, Not set

Tel-Aviv Sourasky Medical Center, Tel Aviv, Not set

Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST - PPDS, Meldola, Emilia-Romagna

Irccs Ospedale San Raffaele, Milano, Lombardia

Asst Grande Ospedale Metropolitano Niguarda, Milano, Lombardia

Istituto Clinico Humanitas, Rozzano (MI), Lombardia

Azienda Ospedaliero Universitaria Pisana, Pisa, Toscana

Aga Khan University Hospital, Nairobi, Not set

Seoul National University Bundang Hospital, Seongnam-si, Not set

Seoul National University Hospital, Seoul, Not set

Asan Medical Center - PPDS, Seoul, Not set

Samsung Medical Center - PPDS, Seoul, Not set

Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis, Amsterdam, Not set

Leids Universitair Medisch Centrum, Leiden, Not set

Maastricht University Medical Center, Maastricht, Not set

Universitair Medisch Centrum Utrecht, Utrecht, Not set

Auckland City Hospital, Cancer and Blood Research, Auckland, Not set

Auckland City Hospital, Auckland, Not set

New Zealand Clinical Research - Christchurch, Christchurch, Not set

Haukeland University Hospital, Bergen, Not set

Oslo university hospital Radiumhospitalet, Oslo, Not set

Uniwersyteckie Centrum Kliniczne, O?rodek Bada? Klinicznych Wczesnych Faz, Gdansk, Not set

Biokinetica, Przychodnia Jozefow, Jozefow, Not set

Uniwersytecki Szpital Kliniczny w Poznaniu, Pozna?, Not set

Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic, Kazan, Tatarstan

Hospital Universitari Vall d'Hebron, Barcelona, Not set

START Madrid-FJD, Hospital Fundacion Jimenez Diaz, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario HM Sanchinarro-CIOCC, Madrid, Not set

Hospital Clinico Universitario Virgen de la Victoria, Malaga, Not set

Hospital Universitario Virgen del Rocío, Sevilla, Not set

Hospital Clinico Universitario de Valencia, Valencia, Not set

Universitaetsspital Basel, Basel, Not set

Inselspital, Bern, Not set

Hôpitaux Universitaires de Genève, Genève, Not set

Unversitätsspital Zürich, Zürich, Not set

Queen Elizabeth Hospital, Birmingham, Not set

Velindre Cancer Centre, Cardiff, Not set

University College London Hospitals NHS Foundation Trust, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Conditions: Non-Small Cell Lung Cancer, Colorectal Cancer, Advanced Solid Tumors

Learn More ›

Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis

NCT04847453

Recruiting

This phase I/Ia trial finds the best dose and side effects of venetoclax given in combination with ixazomib citrate and dexamethasone in treating patients with light chain amyloidosis that has come back (relapsed) or does not respond to treatment (refractory) and who have an abnormal genetic change \[translocation t(11;14)\]. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer c... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: City of Hope Comprehensive Cancer Center LAO, Duarte, California +16 locations

Conditions: AL Amyloidosis

Learn More ›

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

NCT05065216

Recruiting

This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limited treatment options. Participants who have or will receive mechanical thrombectomy (MT) are not eligible for participation. Additionally, participants who have received fibrinolytics are excluded unl... Read More

Gender:

ALL

Ages:

Between 18 years and 90 years

Trial Updated:

04/11/2025

Locations: Gulf Health Hospitals d/b/a Thomas Hospital, Fairhope, Alabama +33 locations

Gulf Health Hospitals d/b/a Thomas Hospital, Fairhope, Alabama

Glendale Adventist Medical Center d/b/a Adventist Health Glendale, Glendale, California

Kaiser Permanente Los Angeles Medical Center, Los Angeles, California

Memorialcare Long Beach Medical Center, Torrance, California

HCA Florida - JFK Medical Center, Atlantis, Florida

Sarasota Memorial Hospital, Sarasota, Florida

Tampa General Hospital (TGH) - The Stroke Center, Tampa, Florida

OSF HealthCare Saint Francis Medical Center, Peoria, Illinois

Community Hospital - MacArthur, Munster, Indiana

Medstar Franklin Square Medical Center, Baltimore, Maryland

Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan

Abbott Northwestern Hospital, Minneapolis, Minnesota

SSM Health DePaul Hospital - St Louis, Bridgeton, Missouri

The University of New Mexico - School of Medicine, Albuquerque, New Mexico

Northwell Health Physician Partners - Neurology at Lenox Hill, New York, New York

Miami Valley Hospital, Dayton, Ohio

The Clinical Neuroscience Institute, Dayton, Ohio

Mercy Health - St. Vincent Medical Center, Toledo, Ohio

The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Ascension St. John, Tulsa, Oklahoma

Oregon Health & Science University, Portland, Oregon

The Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

Prisma Health-Greenville Memorial Hospital, Greenville, South Carolina

Erlanger Hospital, Chattanooga, Tennessee

Chattanooga Center for Neurologic Research, Chattanooga, Tennessee

Ballad Health, Johnson City, Tennessee

Houston Methodist Neurological Institute, Houston, Texas

Memorial Hermann Hospital, Texas Medical Center, Houston, Texas

Vancouver General Hospital, Vancouver, British Columbia

West Georgia Medical Center LTD, Kutaisi, Not set

Israel-Georgia Medical Research Clinic-Healthycore LTD, Tbilisi, Not set

New Hospitals LTD, Tbilisi, Not set

Pineo Medical Ecosystem LTD, Tbilisi, Not set

JSC K. Eristavi National Center of Experimental and Clinical Surgery, Tbilisi, Not set

Conditions: Acute Stroke, Ischemic Stroke, Stroke

Learn More ›

Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative Radiotherapy

NCT05283564

Recruiting

The purpose of this research is to evaluate and determine the rate of successful administration of Percussive ventilation breathhold (PVB) to allow for more accurate radiotherapy for lung tumors.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: Stanford Cancer Institute, Palo Alto, California

Conditions: Lung Cancer

Learn More ›

Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia

NCT05519579

Recruiting

Changing the schedule of intrathecal chemotherapy to be given before and during blinatumomab will maintain the anti-leukemic effects of this drug while at the same time adding the benefit of limiting the neurotoxicity associated with cytokine release.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: Northside Hospital, Atlanta, Georgia

Conditions: Acute Lymphoblastic Leukemia

Learn More ›

Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)

NCT05638295

Recruiting

This phase II ComboMATCH treatment trial tests how well AMG 510 (sotorasib) with or without panitumumab works in treating patients with KRAS G12C mutant solid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Sotorasib is in a class of medications called KRAS inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells. Pan... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama +158 locations

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama

University of South Alabama Mitchell Cancer Institute, Mobile, Alabama

The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles, California

Cedars Sinai Medical Center, Los Angeles, California

VA Palo Alto Health Care System, Palo Alto, California

UM Sylvester Comprehensive Cancer Center at Aventura, Aventura, Florida

UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida

UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs, Florida

UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida

Mayo Clinic in Florida, Jacksonville, Florida

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida

UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida

UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida

Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho

Saint Luke's Cancer Institute - Boise, Boise, Idaho

Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho

Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho

Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho

Saint Luke's Cancer Institute - Meridian, Meridian, Idaho

Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho

Saint Luke's Cancer Institute - Nampa, Nampa, Idaho

Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho

Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho

Advocate Good Shepherd Hospital, Barrington, Illinois

John H Stroger Jr Hospital of Cook County, Chicago, Illinois

University of Illinois, Chicago, Illinois

Advocate Illinois Masonic Medical Center, Chicago, Illinois

AMG Crystal Lake - Oncology, Crystal Lake, Illinois

Carle at The Riverfront, Danville, Illinois

Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois

Decatur Memorial Hospital, Decatur, Illinois

Advocate Good Samaritan Hospital, Downers Grove, Illinois

Carle Physician Group-Effingham, Effingham, Illinois

Crossroads Cancer Center, Effingham, Illinois

Advocate Sherman Hospital, Elgin, Illinois

Advocate South Suburban Hospital, Hazel Crest, Illinois

AMG Libertyville - Oncology, Libertyville, Illinois

Condell Memorial Hospital, Libertyville, Illinois

Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois

Loyola University Medical Center, Maywood, Illinois

Cancer Care Center of O'Fallon, O'Fallon, Illinois

Advocate Christ Medical Center, Oak Lawn, Illinois

Advocate Outpatient Center - Oak Lawn, Oak Lawn, Illinois

Advocate High Tech Medical Park, Palos Heights, Illinois

Advocate Lutheran General Hospital, Park Ridge, Illinois

Memorial Hospital East, Shiloh, Illinois

Southern Illinois University School of Medicine, Springfield, Illinois

Springfield Clinic, Springfield, Illinois

Springfield Memorial Hospital, Springfield, Illinois

Carle Cancer Center, Urbana, Illinois

UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa

UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa

UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa

University of Kentucky/Markey Cancer Center, Lexington, Kentucky

Lafayette Family Cancer Center-EMMC, Brewer, Maine

University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland

National Institutes of Health Clinical Center, Bethesda, Maryland

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan

Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan

Trinity Health Medical Center - Brighton, Brighton, Michigan

Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan

Trinity Health Medical Center - Canton, Canton, Michigan

Chelsea Hospital, Chelsea, Michigan

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan

Corewell Health Dearborn Hospital, Dearborn, Michigan

Corewell Health Farmington Hills Hospital, Farmington Hills, Michigan

Cancer Hematology Centers - Flint, Flint, Michigan

Genesee Hematology Oncology PC, Flint, Michigan

Genesys Hurley Cancer Institute, Flint, Michigan

Hurley Medical Center, Flint, Michigan

University of Michigan Health - Sparrow Lansing, Lansing, Michigan

Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan

Corewell Health Children's, Royal Oak, Michigan

Corewell Health William Beaumont University Hospital, Royal Oak, Michigan

MyMichigan Medical Center Saginaw, Saginaw, Michigan

Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan

MyMichigan Medical Center Tawas, Tawas City, Michigan

Corewell Health Beaumont Troy Hospital, Troy, Michigan

Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan

Huron Gastroenterology PC, Ypsilanti, Michigan

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan

Essentia Health - Deer River Clinic, Deer River, Minnesota

Essentia Health Cancer Center, Duluth, Minnesota

Essentia Health Hibbing Clinic, Hibbing, Minnesota

Mayo Clinic in Rochester, Rochester, Minnesota

Essentia Health Sandstone, Sandstone, Minnesota

Essentia Health Virginia Clinic, Virginia, Minnesota

Saint Francis Medical Center, Cape Girardeau, Missouri

Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri

Washington University School of Medicine, Saint Louis, Missouri

Siteman Cancer Center-South County, Saint Louis, Missouri

Siteman Cancer Center at Christian Hospital, Saint Louis, Missouri

Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri

Community Hospital of Anaconda, Anaconda, Montana

Billings Clinic Cancer Center, Billings, Montana

Bozeman Health Deaconess Hospital, Bozeman, Montana

Benefis Sletten Cancer Institute, Great Falls, Montana

Logan Health Medical Center, Kalispell, Montana

Community Medical Center, Missoula, Montana

OptumCare Cancer Care at Seven Hills, Henderson, Nevada

OptumCare Cancer Care at Charleston, Las Vegas, Nevada

Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada

OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

University of New Mexico Cancer Center, Albuquerque, New Mexico

Roswell Park Cancer Institute, Buffalo, New York

NYU Langone Hospital - Long Island, Mineola, New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York

Columbus Oncology and Hematology Associates Inc, Columbus, Ohio

Riverside Methodist Hospital, Columbus, Ohio

Grant Medical Center, Columbus, Ohio

Doctors Hospital, Columbus, Ohio

Dayton Physician LLC - Englewood, Dayton, Ohio

Delaware Health Center-Grady Cancer Center, Delaware, Ohio

Grady Memorial Hospital, Delaware, Ohio

Columbus Oncology and Hematology Associates, Dublin, Ohio

Dublin Methodist Hospital, Dublin, Ohio

Kettering Medical Center, Kettering, Ohio

OhioHealth Mansfield Hospital, Mansfield, Ohio

OhioHealth Marion General Hospital, Marion, Ohio

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Saint Alphonsus Cancer Care Center-Ontario, Ontario, Oregon

Providence Portland Medical Center, Portland, Oregon

Providence Saint Vincent Medical Center, Portland, Oregon

ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

Asplundh Cancer Pavilion, Willow Grove, Pennsylvania

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee

University of Virginia Cancer Center, Charlottesville, Virginia

Swedish Medical Center-First Hill, Seattle, Washington

ThedaCare Regional Cancer Center, Appleton, Wisconsin

Duluth Clinic Ashland, Ashland, Wisconsin

ThedaCare Cancer Care - Berlin, Berlin, Wisconsin

Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin

Aurora Saint Luke's South Shore, Cudahy, Wisconsin

Aurora Health Care Germantown Health Center, Germantown, Wisconsin

Aurora Cancer Care-Grafton, Grafton, Wisconsin

Aurora BayCare Medical Center, Green Bay, Wisconsin

Mercyhealth Hospital and Cancer Center - Janesville, Janesville, Wisconsin

Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin

Gundersen Lutheran Medical Center, La Crosse, Wisconsin

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin

University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin

Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin

Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin

Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin

Aurora Sinai Medical Center, Milwaukee, Wisconsin

ThedaCare Regional Medical Center - Neenah, Neenah, Wisconsin

ThedaCare Cancer Care - New London, New London, Wisconsin

ThedaCare Cancer Care - Oshkosh, Oshkosh, Wisconsin

Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin

Aurora Cancer Care-Racine, Racine, Wisconsin

ThedaCare Cancer Care - Shawano, Shawano, Wisconsin

Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin

Aurora Medical Center in Summit, Summit, Wisconsin

Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin

ThedaCare Cancer Care - Waupaca, Waupaca, Wisconsin

Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin

Aurora West Allis Medical Center, West Allis, Wisconsin

Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm

Learn More ›

The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

NCT05811364

Recruiting

The objective of this prospective, multicenter, randomized, controlled clinical trial is to demonstrate the superiority of the VBX Device for primary patency when compared to bare metal stenting in complex iliac occlusive disease.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: North Suburban Medical Center, Denver, Colorado +6 locations

Conditions: Aortoiliac Occlusive Disease, Peripheral Arterial Disease

Learn More ›

Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial

NCT05928806

Recruiting

This study is a randomized, open label, multicenter Phase II trial to evaluate the efficacy and safety of botensilimab (a novel Fc enhanced Tree depleting anti-CTLA4) and balstilimab (a novel anti-PD1) relative to ipilimumab and nivolumab in treatment naïve patients with metastatic ccRCC. The study will plan to enroll 120 eligible patients randomized in a 2:1 fashion to Arm A and Arm B. Patients in all IMDC Risk Groups are included. This study utilizes a Simon's two stage design which is describ... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: University of California San Diego, La Jolla, California +12 locations

Conditions: Advanced Renal Cell Carcinoma

Learn More ›

Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease

NCT06046248

Recruiting

This is an open-label, Phase 2 study designed to evaluate the safety and efficacy of belumosudil and rituximab as primary treatment of cGVHD.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: Northside Hospital, Atlanta, Georgia

Conditions: Chronic Graft Versus Host Disease

Learn More ›

Ketamine for Veterans With Parkinson's Disease

NCT06231563

Recruiting

Parkinson's disease (PD) is a devastating illness that has a growing impact on Veterans. One of the most disabling symptoms is depression, which is common in PD and linked to poor quality of life and higher risk of suicide. Unfortunately, there is a lack of effective treatments for depression in PD. Ketamine, which has rapid and potent antidepressant effects, is a potential option but has not been tested in Veterans with PD. Studies in rodents show that ketamine may not only improve depression i... Read More

Gender:

ALL

Ages:

Between 40 years and 80 years

Trial Updated:

04/11/2025

Locations: San Francisco VA Medical Center, San Francisco, CA, San Francisco, California

Conditions: Parkinson's Disease

Learn More ›